Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Research Council grant · Running

VIR-Quantify Nanowire device for single virus delivery and sensing in vacuum

Coordinator
Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
Runs
1 July 2024 to 31 December 2025
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101157423

What the project is doing

In the project's own words, from its summary on CORDIS.

Airborne viruses causing respiratory diseases represent a mayor global health threat, being viruses with RNA-genomes from animal reservoirs highly likely to cause further public health emergencies in the future. VIR-Quantify aims to provide proof of concept for a technology capable of highly sensitive, fast and untargeted airborne virus detection with infectivity assessment, providing a comparative advantage in the competitive landscape.

VIR-Quantify builds upon an unprecedented application of NMS sensors to the field of airborne viral particles detection (methodology developed and patented by the PI in the framework of a previous ERC CoG). VIR-Quantify proposes the use of ionic liquids to preserve the virus structure, together nanowire sensors that allow mass and stiffness measurements for identification and infectivity studies of the pathogens. The innovative solution lies in two fronts: 1) an unprecedented capability to measure with high throughput (30 particles/minute) the stiffness of intact viruses to infer their infectivity potential, not at reach to other techniques, 2) the capability to count and characterize all the viral particles present in the liquid sample without loss of bioanalytes during the measurements.

VIR-Quantify aims to exploit the novel technology for on-site identification and quantification of airbone viral particles and validate the innovation potential of such technological tool for commercialization by developing a market entry strategy built upon IPR consolidation and spin-off set-up. This will lead to high-gain, disruptive outcomes in the form of unprecedented mechanistic understanding for detecting the quick spread of airbone viral particles with great socioeconomic benefits visible at three levels: (1) fuelling industrial innovation and economic growth in a game-changing sector (preventive medicine); (2) reducing healthcare costs worldwide, thus enabling more resilient and efficient health systems; (3) improving human welfare.

Topics

Who is involved

OrganisationCityCountryRole
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI